FDA Committee Votes in Favor of Glaucoma Drug’s Efficacy

Clinical Trials Advisor
A A
An FDA advisory committee voted 10-0 in favor of the efficacy of a drug candidate for treatment of glaucoma and ocular hypertension based on data from efficacy trials.

To View This Article:

Login

Subscribe To Clinical Trials Advisor